@article{Bellini_Cortegiani_Vetrugno_Potì_Saturno_Craca_Bignami_2021, title={COVID-19 … What are drugs and strategies now?}, volume={92}, url={https://mattioli1885journals.com/index.php/actabiomedica/article/view/11165}, DOI={10.23750/abm.v92i2.11165}, abstractNote={&amp;lt;p&amp;gt;From February 2019 the World faces the Covid19 pandemic. The data in our possession are still insufficient to effectively combat this pathology.&amp;lt;/p&amp;gt; &amp;lt;p&amp;gt;The gold standard for diagnosis remains molecular testing, while clinical and instrumental and serological diagnostics are highly nonspecific leading to a slowdown in the battle against covid19.[3]&amp;lt;/p&amp;gt; &amp;lt;p&amp;gt;Can Artificial Intelligence (AI) and Machine Learning (ML) help us? The use of large databases to cross-reference data to stratify the diagnostic scores, to quickly differentiate a critical Covid-19 patient from a non-critical one is the challenge of the future. All to achieve better management of resources in the field and a more effective therapeutic approach.[2]&amp;lt;/p&amp;gt;}, number={2}, journal={Acta Biomedica Atenei Parmensis}, author={Bellini, Valentina and Cortegiani, Andrea and Vetrugno, Luigi and Potì, Francesco and Saturno, Francesco and Craca, Michelangelo and Bignami, Elena}, year={2021}, month={May}, pages={e2021096} }